Jim Simons Renaissance Technologies
Jim Simons is the founder of Renaissance Technologies, one of the most successful quantitative hedge funds in the world. Before his career in finance, he served as a mathematics professor and made significant contributions to differential geometry. Simons applied his analytical expertise to develop sophisticated, algorithm-driven trading strategies, earning consistently high returns for investors.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
PepsiCo
PEP
|
+$192M |
| 2 |
Johnson & Johnson
JNJ
|
+$179M |
| 3 |
EMC
EMC CORPORATION
EMC
|
+$177M |
| 4 |
Chubb
CB
|
+$153M |
| 5 |
Eli Lilly
LLY
|
+$142M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Apple
AAPL
|
+$470M |
| 2 |
PRE
PARTNERRE LTD
PRE
|
+$186M |
| 3 |
Comcast
CMCSA
|
+$179M |
| 4 |
Pfizer
PFE
|
+$168M |
| 5 |
Gilead Sciences
GILD
|
+$144M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 12.85% |
| 2 | Technology | 12.31% |
| 3 | Financials | 12.27% |
| 4 | Industrials | 10.64% |
| 5 | Consumer Staples | 10.39% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1126
Quad
QUAD
$505M
| $10.2M | 0.02% |
790,000
+319,700
| +68% | +$3.46M |
|
|
WNR
1127
DELISTED
Western Refining Inc
WNR
| $10.2M | 0.02% |
351,100
-210,200
| -37% | -$6.34M |
|
|
BEAT
1128
DELISTED
BioTelemetry, Inc.
BEAT
| $10.2M | 0.02% |
873,900
+54,300
| +7% | +$607K |
|
|
SHLX
1129
DELISTED
Shell Midstream Partners, L.P.
SHLX
| $10.2M | 0.02% |
+278,343
| New | +$9.81M |
|
1130
Pacific Biosciences
PACB
$354M
| $10.1M | 0.02% |
1,188,700
-397,700
| -25% | -$3.91M |
|
|
CHMT
1131
DELISTED
Chemtura Corporation
CHMT
| $10M | 0.02% |
380,068
-172,900
| -31% | -$4.42M |
|
|
CHSP
1132
DELISTED
Chesapeake Lodging Trust
CHSP
| $10M | 0.02% |
378,600
+135,800
| +56% | +$3.42M |
|
|
HMHC
1133
DELISTED
Houghton Mifflin Harcourt Company
HMHC
| $9.99M | 0.02% |
500,800
+285,000
| +132% | +$5.25M |
|
1134
Roper Technologies
ROP
$38.6B
| $9.94M | 0.02% |
+54,400
| New | +$9.37M |
|
|
ARC
1135
DELISTED
ARC Document Solutions, Inc.
ARC
| $9.94M | 0.02% |
2,208,800
+325,000
| +17% | +$1.22M |
|
|
JIVE
1136
DELISTED
Jive Software, Inc.
JIVE
| $9.94M | 0.02% |
2,629,300
+118,800
| +5% | +$413K |
|
1137
T. Rowe Price
TROW
$23.4B
| $9.93M | 0.02% |
135,200
-128,000
| -49% | -$8.89M |
|
1138
Deluxe
DLX
$1.11B
| $9.93M | 0.02% |
158,900
+108,000
| +212% | +$6.02M |
|
|
RATE
1139
DELISTED
Bankrate Inc
RATE
| $9.91M | 0.02% |
1,080,400
+681,100
| +171% | +$7.11M |
|
|
CLVS
1140
DELISTED
Clovis Oncology, Inc.
CLVS
| $9.9M | 0.02% |
+515,400
| New | +$10.9M |
|
1141
AMC Entertainment Holdings
AMC
$2.29B
| $9.89M | 0.02% |
35,320
+1,070
| +3% | +$256K |
|
|
PFSW
1142
DELISTED
PFSweb, Inc.
PFSW
| $9.88M | 0.02% |
752,939
-276,900
| -27% | -$3.43M |
|
1143
Bio-Techne
TECH
$11.2B
| $9.84M | 0.02% |
416,400
-222,800
| -35% | -$4.91M |
|
|
SAND
1144
DELISTED
Sandstorm Gold
SAND
| $9.83M | 0.02% |
2,989,245
+1,052,045
| +54% | +$2.9M |
|
|
HPP
1145
Hudson Pacific Properties
HPP
$781M
| $9.83M | 0.02% |
48,557
-3,721
| -7% | -$676K |
|
|
HOT
1146
DELISTED
STARWOOD HOTELS & RESORTS WORLDWIDE, INC.
HOT
| $9.83M | 0.02% |
117,800
-936,100
| -89% | -$63.9M |
|
|
AEGN
1147
DELISTED
Aegion Corp
AEGN
| $9.83M | 0.02% |
465,896
+145,096
| +45% | +$2.71M |
|
1148
MGIC Investment
MTG
$6.36B
| $9.82M | 0.02% |
1,280,800
-1,891,800
| -60% | -$13.6M |
|
|
ZVO
1149
DELISTED
Zovio Inc. Common Stock
ZVO
| $9.8M | 0.02% |
972,258
+184,448
| +23% | +$1.4M |
|
1150
Silicon Laboratories
SLAB
$7.3B
| $9.8M | 0.02% |
+217,898
| New | +$9.37M |
|
Similar funds
Jim Simons's Q1 2016 Portfolio in Review
As of Q1 2016, Jim Simons held 3,753 positions worth $52.6B, up 15% from $45.9B the previous quarter. Its ten largest holdings account for 7.9% of the portfolio.
Jim Simons deployed $5.31B of net new capital in Q1 2016, opening 498 new positions and adding to 2,018 existing holdings. Its largest new stake was EMC CORPORATION: 7,000,400 shares worth $187M.
By sector, the portfolio is most concentrated in Healthcare at 13% of assets, down from 14% a quarter earlier, followed by Technology and Financials.
On the sell side, the largest reduction was Pfizer, an estimated $168M trimmed.
- Jim Simons's largest Q1 2016 buy was EMC CORPORATION: 7,000,400 shares worth $187M.
- Jim Simons added most to PepsiCo in Q1 2016, an estimated $192M increase.
- Jim Simons's biggest Q1 2016 reduction was Pfizer, cutting an estimated $168M.
- Jim Simons fully exited Apple in Q1 2016, selling an estimated $470M.
- Jim Simons's ten largest holdings make up 7.9% of its $52.6B portfolio in Q1 2016.
- Jim Simons opened 498 new positions and closed 403 in Q1 2016.
- Jim Simons's portfolio value rose 15% quarter-over-quarter to $52.6B.
Based on Renaissance Technologies's 13F filing for Q1 2016, filed 13 May 2016.